**Summary:**
Australian startup Cauldron Ferm claims to have resolved a major hurdle in synthetic biology by converting microbes into continuously operating production lines, benefiting its clientele of synthetic biology companies.

**Key Points:**
– Cauldron Ferm has developed a solution for a significant issue in synthetic biology.
– The startup’s innovation enables microbes to enhance production processes continuously.
– Its customer base primarily comprises synthetic biology companies.

Read full article: undefined